Internal Medicine · Clayton, GA
NPI
1386710085
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
156 N Main St
Clayton, GA, 30525
Phone (706) 212-0390
Groups this clinician bills Medicare through
Medicare paid, 2024
$194K
5,053 services
Medicare patients, 2024
415
Average age 76
Drug cost, 2024
$2.2M
14,556 prescriptions
Company payments, 2025
$430
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward D Frederickson was code 99214 (office e&m - established), 1,046 times for 364 patients. In total Edward D Frederickson billed 5,053 services in 50 codes, and Medicare paid $194K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,046 | 364 | $89.62 | $94K |
| 99458 E&M - Miscellaneous | Office | 715 | 62 | $29.24 | $21K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 544 | 116 | $0.64 | $349 |
| 99457 E&M - Miscellaneous | Office | 518 | 68 | $35.82 | $19K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 394 | 115 | $0.08 | $29.55 |
| 99454 E&M - Miscellaneous | Office | 354 | 52 | $32.58 | $12K |
| 99213 Office E&M - Established | Office | 344 | 209 | $63.15 | $22K |
| 99211 Office E&M - Established | Office | 300 | 165 | $15.29 | $4,588 |
| 96372 Injection Administration | Office | 200 | 121 | $10.12 | $2,024 |
| 93000 Electrocardiogram | Office | 88 | 77 | $10.08 | $887 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 46 | 46 | $128.73 | $5,922 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 40 | 17 | $0.98 | $39.02 |
| 87635 COVID Specific | Office | 34 | 32 | $23.78 | $809 |
| 99204 Office E&M - New | Office | 34 | 34 | $97.46 | $3,314 |
| 87804 Immunoassay | Office | 30 | 29 | $15.68 | $470 |
By year: 2022 $155K for 4,855 services; 2023 $202K for 5,551 services; 2024 $194K for 5,053 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87635 COVID Specific | 34 | 32 | $23.78 | $809 |
| 87804 Immunoassay | 30 | 29 | $15.68 | $470 |
| 87880 Immunoassay | 21 | 21 | $15.43 | $324 |
| 81002 Clinical Chemistry | 19 | 16 | $3.41 | $64.79 |
Medicare prescription drug claims, 2024
In 2024, the drug Edward D Frederickson prescribed most often to Medicare patients was Metoprolol Succinate, with 648 prescriptions and refills. In total Edward D Frederickson wrote 14,556 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 648 | 1,834 | 203 | $7,959 |
| Levothyroxine Sodium Generic | 628 | 1,682 | 160 | $6,287 |
| Atorvastatin Calcium Generic | 477 | 1,309 | 137 | $3,778 |
| Omeprazole Generic | 359 | 955 | 120 | $5,949 |
| Rosuvastatin Calcium Generic | 345 | 1,002 | 110 | $3,443 |
| Furosemide Generic | 294 | 799 | 109 | $2,028 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 293 | 293 | 75 | $6,042 |
| Atenolol Generic | 285 | 834 | 84 | $1,859 |
| Mounjaro Tirzepatide | 281 | 332 | 45 | $353K |
| Alprazolam Generic | 274 | 335 | 49 | $1,266 |
| Amlodipine Besylate Generic | 272 | 765 | 88 | $1,587 |
| Pantoprazole Sodium Generic | 262 | 665 | 82 | $3,102 |
| Losartan Potassium Generic | 257 | 720 | 78 | $2,790 |
| Clonazepam Generic | 239 | 295 | 51 | $1,609 |
| Tamsulosin Hcl Generic | 237 | 597 | 68 | $2,581 |
Brand drugs: 2,006 claims; generic drugs: 12,489 claims; opioid claims: 663.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward D Frederickson $430 ($430 in general payments such as food, travel and fees) from 8 companies. The largest payer was Novo Nordisk Inc with $242.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.